ClinVar Miner

Submissions for variant NM_030777.4(SLC2A10):c.455C>T (p.Ala152Val)

gnomAD frequency: 0.00001  dbSNP: rs775987124
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 3
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
GeneDx RCV000521329 SCV000620070 uncertain significance not provided 2017-08-17 criteria provided, single submitter clinical testing A variant of uncertain significance has been identified in the SLC2A10 gene. The A152V variant has not been published as pathogenic or been reported as benign to our knowledge. This variant is not observed at a significant frequency in large population cohorts (Lek et al., 2016; 1000 Genomes Consortium et al., 2015; Exome Variant Server). However, the A152V variant is a conservative amino acid substitution, which is not likely to impact secondary protein structure as these residues share similar properties. This substitution occurs at a position that is not conserved across species, and in silico analysis suggests that this variant likely does not alter the protein structure/function.
Ambry Genetics RCV002314915 SCV000739660 uncertain significance Familial thoracic aortic aneurysm and aortic dissection 2017-04-25 criteria provided, single submitter clinical testing The p.A152V variant (also known as c.455C>T), located in coding exon 2 of the SLC2A10 gene, results from a C to T substitution at nucleotide position 455. The alanine at codon 152 is replaced by valine, an amino acid with similar properties. This amino acid position is not well conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear.
Invitae RCV001312628 SCV001503088 uncertain significance Arterial tortuosity syndrome 2021-11-04 criteria provided, single submitter clinical testing This sequence change replaces alanine, which is neutral and non-polar, with valine, which is neutral and non-polar, at codon 152 of the SLC2A10 protein (p.Ala152Val). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt SLC2A10 protein function. ClinVar contains an entry for this variant (Variation ID: 451377). This variant has not been reported in the literature in individuals affected with SLC2A10-related conditions. This variant is present in population databases (rs775987124, gnomAD 0.002%).

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.